ONE-WAYDated event · through FY2025
AI- and joint research-based biomarker discovery for clinical trials
A focus on discovering biomarkers, through joint research with Kyoto University, Fujitsu and the National Cancer Center and the use of AI, that can support patient stratification, improve the probability of success in clinical trials and shorten development timelines.
Companies1How many companies write about this.
Threads1One company can carry more than one thread here.
PeriodFY2024 →Last written FY2025
Directionhelps1 helps · 0 hurts · 0 flat